BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Aug 27, 2026; 18(8): 121272
Published online Aug 27, 2026. doi: 10.4240/wjgs.121272
Table 2 Baseline demographic and clinical characteristics stratified by inflammation/nutrition-based combined score, median (interquartile range)/n (%)
Variable
Total (n = 154)
Low score (0-3, n = 121)
High score (4-6, n = 33)
P value
Age (years) 68 (61-76)67 (60-74)75 (70-83)< 0.001a
Sex (male)96 (62.3)78 (64.5)18 (54.5)0.401
Type of surgery0.050
Subtotal59 (38.3)41 (33.9)18 (54.5)
Total95 (61.7)80 (66.1)15 (45.5)
Neoadjuvant chemotherapy29 (18.8)25 (20.7)4 (12.1)0.389
Overall mortality94 (61.0)65 (53.7)29 (87.9)< 0.001a
TNM stagen = 1510.016a
Stage I19 (12.6)18 (14.9)1 (3.0)
Stage II45 (29.8)39 (32.2)6 (18.2)
Stage III65 (43.0)48 (39.7)17 (51.5)
Stage IV22 (14.6)13 (10.7)9 (27.3)
Perineural invasion107/153 (69.9)79 (65.3)28 (84.8)0.058
Differentiation (poor)n = 1080.136
Poor48 (44.4)36 (29.8)12 (36.4)
Moderate43 (39.8)30 (24.8)13 (39.4)
Good17 (15.7)16 (13.2)1 (3.0)


Write to the Help Desk